Importantly, we have screened several PI3K inhibitors and identified PIK75 as a potent PI3K inhibitor taken effect on endosomal PI3K, which even led to degradation of p110ɑ and p85 in tumor cells at modest dosage. Here, PIK3R1 is linked to neoplasm.